1-4 of 4
Dae Ho Lee, MD
Close
Sort by
Journal Articles

Comparison Between CD20-Negative and CD20-Positive Diffuse Large B Cell Lymphoma; Characteristics and Clinical Outcome

Jungmin Jo, M.D, Changhoon Yoo, M.D, Yongchel Ahn, MD, Seong Joon Park, M.D, Shin Kim, RN, Dae Ho Lee, MD, Sang We Kim, MD, Jungsin Lee, MD, Cheolwon Suh, MD
Journal: Blood
Blood (2010) 116 (21): 4891.
https://doi.org/10.1182/blood.V116.21.4891.4891
Published: 2010
Journal Articles

The Role of High Dose Chemotherapy/Autologous Stem Cell Transplantation for Salvage Treatment for Relapsed Peripheral T Cell Lymphoma.

Yoojin Cho, MD, Myoung Joo Kang, MD, Dae Ro Choi, MD, Eun Kyoung Kim, MD, Shin Kim, Dae Ho Lee, MD, Sang We Kim, MD, Jooryung Huh, MD, Jeong Shin Lee, MD, Cheolwon Suh, M.D.
Journal: Blood
Blood (2009) 114 (22): 4363.
https://doi.org/10.1182/blood.V114.22.4363.4363
Published: 2009
Journal Articles

The Role of An Early Interim 18 F-FDG PET/CT for Prediction of Outcomes of Patients with Peripheral T Cell Lymphoma

Yoon Hee Choi, MD, Byung Woog Kang, MD, Hyun Soo Hong, MD, Chul Kim, MD, Geundoo Jang, MD, Sung Sook Lee, MD, Jin Sook Ryu, MD, Jooryung Huh, MD, Dae Ho Lee, MD, Sang We Kim, MD, Jung Shin Lee, MD, Cheolwon Suh, MD
Journal: Blood
Blood (2008) 112 (11): 5272.
https://doi.org/10.1182/blood.V112.11.5272.5272
Published: 2008
Journal Articles

A Phase I Trial of Bortezomib Plus CHOP Every 2 Weeks in Patients with Advanced Stage Diffuse Large B-Cell Lymphomas.

Geundoo Jang, MD, Sun-Jin Sym, MD, Shin Kim, Dae Ho Lee, MD, Sang We Kim, MD, Jooryung Huh, MD, Won Seog Kim, MD, Cheolwon Suh, MD
Journal: Blood
Blood (2007) 110 (11): 4446.
https://doi.org/10.1182/blood.V110.11.4446.4446
Published: 2007